rs56113850
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000762.6(CYP2A6):c.655-151A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.545 in 1,201,092 control chromosomes in the GnomAD database, including 184,585 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.52 ( 21334 hom., cov: 31)
Exomes 𝑓: 0.55 ( 163251 hom. )
Consequence
CYP2A6
NM_000762.6 intron
NM_000762.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.62
Publications
89 publications found
Genes affected
CYP2A6 (HGNC:2610): (cytochrome P450 family 2 subfamily A member 6) This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008]
CYP2A6 Gene-Disease associations (from GenCC):
- coumarin resistanceInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
- nicotine dependenceInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.577 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CYP2A6 | ENST00000301141.10 | c.655-151A>G | intron_variant | Intron 4 of 8 | 1 | NM_000762.6 | ENSP00000301141.4 | |||
| CYP2A6 | ENST00000596719.5 | n.506-151A>G | intron_variant | Intron 3 of 5 | 1 | |||||
| CYP2A6 | ENST00000600495.1 | n.*467-151A>G | intron_variant | Intron 4 of 5 | 1 | ENSP00000472905.1 | ||||
| ENSG00000268797 | ENST00000601627.1 | n.118-44789T>C | intron_variant | Intron 1 of 3 | 3 | ENSP00000469533.1 |
Frequencies
GnomAD3 genomes AF: 0.518 AC: 78260AN: 151024Hom.: 21327 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
78260
AN:
151024
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.549 AC: 576353AN: 1049954Hom.: 163251 AF XY: 0.545 AC XY: 281459AN XY: 516868 show subpopulations
GnomAD4 exome
AF:
AC:
576353
AN:
1049954
Hom.:
AF XY:
AC XY:
281459
AN XY:
516868
show subpopulations
African (AFR)
AF:
AC:
9090
AN:
23280
American (AMR)
AF:
AC:
11478
AN:
19116
Ashkenazi Jewish (ASJ)
AF:
AC:
10063
AN:
17416
East Asian (EAS)
AF:
AC:
9264
AN:
30624
South Asian (SAS)
AF:
AC:
22513
AN:
55538
European-Finnish (FIN)
AF:
AC:
23245
AN:
41598
Middle Eastern (MID)
AF:
AC:
1631
AN:
3102
European-Non Finnish (NFE)
AF:
AC:
464934
AN:
814260
Other (OTH)
AF:
AC:
24135
AN:
45020
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
11793
23586
35379
47172
58965
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
12390
24780
37170
49560
61950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.518 AC: 78291AN: 151138Hom.: 21334 Cov.: 31 AF XY: 0.514 AC XY: 37894AN XY: 73790 show subpopulations
GnomAD4 genome
AF:
AC:
78291
AN:
151138
Hom.:
Cov.:
31
AF XY:
AC XY:
37894
AN XY:
73790
show subpopulations
African (AFR)
AF:
AC:
16533
AN:
41082
American (AMR)
AF:
AC:
8900
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
AC:
1992
AN:
3468
East Asian (EAS)
AF:
AC:
1613
AN:
4964
South Asian (SAS)
AF:
AC:
1972
AN:
4766
European-Finnish (FIN)
AF:
AC:
5956
AN:
10486
Middle Eastern (MID)
AF:
AC:
165
AN:
294
European-Non Finnish (NFE)
AF:
AC:
39440
AN:
67844
Other (OTH)
AF:
AC:
1104
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1849
3698
5546
7395
9244
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
676
1352
2028
2704
3380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1465
AN:
3434
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.